|
|
|
Insider
Information: |
Schimmel Paul |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
1,717,702 |
|
Indirect Shares
|
1,312,785 |
|
|
Direct
Value |
$98,302,233 |
|
|
Indirect Value
|
$46,356,416 |
|
|
Total
Shares |
3,030,487 |
|
|
Total
Value |
$144,658,649 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2018-03-13 |
0 |
2018-03-13 |
306,996 |
Premium* |
|
Repligen Corp |
RGEN |
Director |
2007-06-14 |
665,106 |
2005-11-07 |
0 |
Premium* |
|
Avicena Group, Inc. |
AVCE |
Director |
2006-12-28 |
1,020,242 |
2005-11-23 |
0 |
Premium* |
|
aTyr Pharma Inc |
LIFE |
Director |
2023-05-10 |
8,890 |
2023-05-10 |
992,166 |
Premium* |
|
Forte Biosciences Inc |
FBRX |
Director |
2017-04-19 |
23,464 |
2017-04-19 |
13,623 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RGEN |
Repligen Corp |
Director |
|
2006-08-11 |
4 |
OE |
$0.88 |
$4,400 |
D/D |
5,000 |
663,106 |
|
- |
|
RGEN |
Repligen Corp |
Director |
|
2007-06-14 |
4 |
OE |
$1.00 |
$5,000 |
D/D |
5,000 |
665,106 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-12 |
4 |
B |
$3.75 |
$9,682 |
D/D |
2,581 |
20,412 |
2.39 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2018-09-04 |
4 |
B |
$0.76 |
$15,709 |
I/I |
20,749 |
735,077 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2018-08-31 |
4 |
B |
$0.72 |
$15,752 |
I/I |
22,000 |
714,328 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-11 |
4/A |
B |
$3.59 |
$18,891 |
D/D |
5,259 |
17,831 |
2.39 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-12-21 |
4 |
B |
$2.28 |
$22,818 |
I/I |
10,000 |
721,814 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-12-16 |
4 |
B |
$2.40 |
$23,973 |
I/I |
10,000 |
696,814 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-12 |
4 |
B |
$3.70 |
$24,220 |
I/I |
6,546 |
240,127 |
2.1 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2015-03-17 |
4 |
OE |
$27.28 |
$25,834 |
D/D |
947 |
947 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2020-05-20 |
4 |
S |
$3.64 |
$30,739 |
I/I |
(8,447) |
429,143 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-12-20 |
4 |
B |
$2.27 |
$34,110 |
I/I |
15,000 |
711,814 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-13 |
4 |
B |
$3.85 |
$37,865 |
I/I |
9,835 |
249,962 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2018-08-29 |
4 |
B |
$0.72 |
$54,090 |
I/I |
75,136 |
603,053 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2018-08-30 |
4 |
B |
$0.76 |
$67,483 |
I/I |
89,275 |
692,328 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2018-11-26 |
4 |
B |
$0.54 |
$79,796 |
I/I |
147,225 |
882,302 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-06 |
4 |
B |
$3.20 |
$80,000 |
D/D |
25,000 |
62,572 |
2.39 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-05 |
4 |
B |
$3.52 |
$88,118 |
D/D |
25,000 |
37,572 |
2.39 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-11 |
4/A |
B |
$3.45 |
$97,643 |
I/I |
27,400 |
233,581 |
2.1 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-12-15 |
4 |
B |
$2.50 |
$99,912 |
I/I |
40,000 |
686,814 |
2.1 |
- |
|
FBRX |
Forte Biosciences Inc |
Director |
|
2017-04-19 |
4 |
B |
$10.00 |
$100,000 |
I/I |
10,000 |
13,623 |
2.1 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2015-03-17 |
4 |
AS |
$120.00 |
$113,640 |
D/D |
(947) |
0 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-11 |
4 |
B |
$3.45 |
$116,535 |
D/D |
32,659 |
220,231 |
2.39 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-07 |
4 |
B |
$3.19 |
$127,584 |
D/D |
40,000 |
102,572 |
2.39 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2016-04-14 |
4 |
B |
$4.14 |
$135,075 |
D/D |
32,600 |
53,012 |
2.39 |
- |
|
84 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|